G04.02 Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis

Name of the Condition

• Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis

Summary

Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis is a rare inflammatory condition affecting the central nervous system, characterized by widespread demyelination following vaccination. It presents with acute neurological symptoms and requires prompt evaluation to distinguish it from other demyelinating or infectious processes.

Causes

This condition is thought to be an autoimmune response triggered by vaccination. The immune system mistakenly attacks myelin, the protective covering of nerve fibers, leading to inflammation and neurological dysfunction. The exact mechanism linking vaccination to this response remains under investigation.

Risk Factors

• Recent vaccination (particularly live attenuated vaccines, though rare).
• History of autoimmune disorders.
• Age (more common in children, though it can occur in adults).
• Genetic predisposition to immune-mediated reactions.

Symptoms

• Rapid onset of neurological symptoms, often within days to weeks of vaccination.
• Altered mental status, confusion, or behavioral changes.
• Weakness, numbness, or paralysis in limbs.
• Visual disturbances (e.g., blurred vision, optic neuritis).
• Seizures or loss of coordination.
• Fever or headache (less common than in infectious encephalitis).

Diagnosis

Diagnosis involves a combination of clinical evaluation, neurological examination, and imaging studies (e.g., MRI) to identify demyelination. Cerebrospinal fluid analysis may show inflammatory changes. Differential diagnosis includes other demyelinating disorders (e.g., multiple sclerosis) or infectious encephalitis. Vaccination history is a key consideration.

Treatment Options

Treatment focuses on reducing inflammation and managing symptoms. High-dose corticosteroids are commonly used to suppress the immune response. Plasmapheresis or intravenous immunoglobulin may be considered in severe cases. Supportive care, including physical therapy and seizure management, is often necessary.

Prognosis and Follow-Up

Prognosis varies; many patients recover with treatment, but some may experience residual neurological deficits. Follow-up includes monitoring for symptom recurrence or progression, and rehabilitation to address functional impairments. Long-term outcomes depend on the extent of initial damage and response to therapy.

Complications

Potential complications include permanent neurological damage (e.g., motor or cognitive deficits), seizures, or relapse. Rarely, severe cases may lead to coma or death. Early intervention improves outcomes, but recovery may be incomplete in some patients.

Lifestyle & Prevention

No specific preventive measures exist beyond vaccination safety protocols. For those with a history of autoimmune reactions, discussing vaccination risks with a healthcare provider is advised. Lifestyle modifications focus on managing symptoms and supporting recovery (e.g., physical therapy, stress reduction).

When to Seek Professional Help

Seek immediate medical attention if neurological symptoms (e.g., weakness, confusion, vision changes) develop shortly after vaccination. Early evaluation is critical to initiate treatment and minimize long-term effects.

Tips for Medical Coders

Use G04.02 for postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis. Document vaccination history, onset timing, and clinical findings to support the diagnosis. Ensure differentiation from other demyelinating or infectious conditions to avoid coding errors.